March 26, 2024 — Medical imaging AI company Avicenna.AI announced that it has received 510(k) clearance from the US Fo

March 26, 2024 — Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II-III obstructive hypertrophic cardiomyopathy at the American College of Cardiology/ACC Annual Scientific Session & Expo, ACC.24, taking place April 6-8, 2024 in Atlanta, Geo

March 26, 2024 — UC San Diego Health is the first health system in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with irregular heart rhythms, known as arrhythmias, which can lead to complications like palpitations, fainting and stroke.

Here is a look at the education and special events planned for the ACC24 73rd Annual Scientific Session & Expo, April 6-8 in Atlanta

The American

March 25, 2024 — In a groundbreaking medical advancement, three esteemed cardiologists from CLS Health, Dr. Bahaeddin Shabaneh, Dr. Fethi Benraouane, and Dr.

March 25, 2024 — Abbott announced the first patient has been enrolled in the ENVISION investigational device exemption (IDE) clinical trial. The global, randomized trial (

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the Massachusetts Institute of Technology (MIT) recently announced in the journal Nature Communications that they had successfully built a tissue-like bioelectronic mesh system integrated with an array of atom-thin graphene sensors that can simultaneously measure both the electrical signal and the physical movement of cells in lab-grown human c

March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal of predicting the risk of thrombosis by quantifying platelet FcγRIIa (pFCG test), announced the acceptance of its abstract titled Association Between Prognostic Implications of Platelet FCɣRIIA (PFCG) and Treatment Strategy for Myocardial Infarction at The American College of Cardiology (ACC) Scientific Sessions 2024 in Atlanta.

March 21, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abiomed is recalling the Instructions for Use for its Impella Left Sided Blood Pumps because the pump catheter may perforate (cut) the wall of the left ventricle in the heart.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now